3. The Fourth Schedule to the Misuse of Drugs Regulations is amended —| (a) | by deleting items (4), (11), (16), (20) and (31) of paragraph 1; | | (b) | by deleting items (2A) and (2B) of paragraph 17 and substituting the following items:| “(2A) | 2‑Amino‑1‑(4‑bromo‑2,5‑dimethoxyphenyl)ethan‑1‑one (also known as bk‑2C‑B) and its bromo and dimethoxy positional isomers in the phenyl ring | | (2B) | N‑(1‑Amino‑3,3‑dimethyl‑1‑oxobutan‑2‑yl)-1‑(cyclohexylmethyl)‑1H‑indazole‑3‑carboxamide (also known as MAB‑CHMINACA) | | (2C) | N‑(1‑Amino‑3,3‑dimethyl‑1‑oxobutan‑2‑yl)-1‑(5‑fluoropentyl)‑1H‑indazole‑3‑carboxamide (also known as 5‑Fluoro‑ADB‑PINACA) and its fluoro positional isomers in the pentyl group | | (2D) | N‑(1‑Amino‑3,3‑dimethyl‑1‑oxobutan‑2‑yl)‑1‑pentyl-1H‑indazole‑3‑carboxamide (also known as ADB‑PINACA) | | (2E) | N‑(1‑Amino‑3‑methyl‑1‑oxobutan‑2‑yl)-1‑(5‑chloropentyl)‑1H‑indazole‑3‑carboxamide (also known as 5‑Chloro‑AB‑PINACA) and its chloro positional isomers in the pentyl group | | (2F) | N‑(1‑Amino‑3‑methyl‑1‑oxobutan‑2‑yl)-1‑(cyclohexylmethyl)‑1H‑indazole‑3‑carboxamide (also known as AB‑CHMINACA) | | (2G) | N‑(1‑Amino‑3‑methyl‑1‑oxobutan‑2‑yl)-1‑(4‑fluorobenzyl)‑1H‑indazole‑3‑carboxamide (also known as AB‑FUBINACA) and its fluoro positional isomers in the phenyl ring | | (2H) | N‑(1‑Amino‑3‑methyl‑1‑oxobutan‑2‑yl)-1‑(5‑fluoropentyl)‑1H‑indazole‑3‑carboxamide (also known as 5‑Fluoro‑AB‑PINACA) and its fluoro positional isomers in the pentyl group | | (2I) | N‑(1‑Amino‑3‑methyl‑1‑oxobutan‑2‑yl)‑1‑pentyl-1H‑indazole‑3‑carboxamide (also known as AB‑PINACA) | | (2J) | N‑(1‑Amino‑1‑oxo‑3‑phenylpropan‑2‑yl)-1‑(5‑fluoropentyl)‑1H‑indazole‑3‑carboxamide (also known as PX‑2) and its fluoro positional isomers in the pentyl group | | (2K) | N‑(1‑Amino‑1‑oxo‑3‑phenylpropan‑2‑yl)-1‑(5‑fluoropentyl)‑1H‑indole‑3‑carboxamide (also known as PX‑1) and its fluoro positional isomers in the pentyl group | | (2L) | 4‑(2‑Aminopropyl)benzofuran (also known as 4‑APB)”; |
|
| | (c) | by inserting, immediately after item (6A) of paragraph 17, the following item:| “(6AA) | 1‑(1‑Benzofuran‑5‑yl)‑N‑ethylpropan‑2‑amine (also known as 5‑EAPB) and its 4‑yl, 6‑yl and 7‑yl isomers”; |
|
| | (d) | by inserting, immediately after item (8A) of paragraph 17, the following item:| “(8B) | 1‑Cyclohexyl‑4‑(1,2‑diphenylethyl)piperazine (also known as MT‑45)”; |
|
| | (e) | by inserting, immediately after item (15A) of paragraph 17, the following item:| “(15B) | 2‑(2,5‑Dimethoxyphenyl)ethanamine (also known as 2C‑H) and its dimethoxy positional isomers in the phenyl ring”; |
|
| | (f) | by inserting, immediately after item (19) of paragraph 17, the following items:| “(19A) | [1‑(5‑Fluoropent‑1‑yl)‑1H‑benzimidazol-2‑yl](naphthalene‑1‑yl)methanone (also known as FUBIMINA) and its fluoro positional isomers in the pentyl group | | (19B) | [1‑(5‑Fluoropent‑1‑yl)‑1H‑indazol‑3‑yl](naphthalen-1‑yl)methanone (also known as THJ‑2201) and its fluoro positional isomers in the pentyl group”; |
|
| | (g) | by deleting item (27A) of paragraph 17 and substituting the following items:| “(27A) | 1‑(1H‑Indol‑5‑yl)propan‑2‑amine (also known as 5‑IT) and its 4‑yl, 6‑yl and 7‑yl isomers | | (27B) | 2‑(4‑Iodo‑2,5‑dimethoxyphenyl)‑N-(2‑methoxybenzyl)ethanamine (also known as 25I‑NBOMe) | | (27C) | 2‑(4‑Iodo‑2,5‑dimethoxyphenyl)ethanamine (also known as 2C‑I) and its dimethoxy and iodo positional isomers in the phenyl ring”; |
|
| | (h) | by inserting, immediately after item (28) of paragraph 17, the following items:| “(28A) | Methyl 2‑[1‑(cyclohexylmethyl)‑1H‑indazole-3‑carboxamido]‑3,3‑dimethylbutanoate (also known as MDMB‑CHMINACA) | | (28B) | Methyl 2‑[1‑(cyclohexylmethyl)‑1H‑indazole-3‑carboxamido]‑3‑methylbutanoate (also known as MA‑CHMINACA) | | (28C) | Methyl 2‑[1‑(5‑fluoropentyl)‑1H‑indazole-3‑carboxamido]‑3‑methylbutanoate (also known as 5‑Fluoro‑AMB) and its fluoro positional isomers in the pentyl group”; |
|
| | (i) | by inserting, immediately after item (30) of paragraph 17, the following item:| “(30A) | 4‑Methyl‑5‑(4‑methylphenyl)‑4,5‑dihydro‑1,3‑oxazol-2‑amine (also known as 4,4’‑Dimethylaminorex, 4,4’‑DMAR or para‑methyl‑4‑methylaminorex) and its methyl positional isomers in the phenyl ring”; |
|
| | (j) | by deleting item (33) of paragraph 17 and substituting the following item:| “(33) | N‑Methyl‑1‑(thiophen‑2‑yl)propan‑2‑amine (also known as methiopropamine) and its thiophen‑3‑yl isomer”; and |
|
| | (k) | by inserting, immediately after paragraph 17, the following paragraph:“18. Any compound (other than serotonin) structurally derived from 2‑(1H‑indol‑3‑yl)ethanamine (also known as tryptamine) by modification in any of the following ways:| (a) | substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of only the nitrogen atom of the side chain in a cyclic structure; | | (b) | substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; | | (c) | substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, hydroxy, thioalkyl, alkylenedioxy, halide or acetoxy substituents; | | (d) | substitution at the 2-position of the tryptamine ring system with an alkyl substituent, |
| including any ether, salt or stereoisomeric form of any such compound, any preparation or product containing any such compound, and the following examples of such a compound: |
| (1) | 4‑Acetoxy‑N,N‑diisopropyltryptamine (also known as 4‑Acetoxy‑DiPT or 4‑AcO‑DiPT) | | (2) | 4‑Acetoxy‑N,N‑dimethyltryptamine (also known as 4‑Acetoxy‑DMT or 4‑AcO‑DMT) | | (3) | 5‑Benzyloxytryptamine | | (4) | 5‑Bromo‑N,N‑dimethyltryptamine (also known as 5‑Bromo‑DMT) | | (5) | 5‑Bromotryptamine | | (6) | 5‑Chloro‑α‑methyltryptamine (also known as 5‑Chloro‑AMT) | | (7) | 5‑Chlorotryptamine | | (8) | N,N‑Diallyltryptamine | | (9) | N,N‑Diethyltryptamine | | (10) | N,N‑Diisopropyltryptamine | | (11) | N,N‑Dimethyltryptamine | | (12) | N,N‑Dipropyltryptamine | | (13) | Etryptamine | | (14) | 5‑Fluoro‑N,N‑dimethyltryptamine (also known as 5‑Fluoro‑DMT) | | (15) | 5‑Fluoro‑α‑methyltryptamine (also known as 5‑Fluoro‑AMT) | | (16) | 5‑Fluorotryptamine | | (17) | 4‑Hydroxy‑N,N‑diethyltryptamine (also known as 4‑Hydroxy‑DET or 4‑HO‑DET) | | (18) | 4‑Hydroxy‑N,N‑diisopropyltryptamine (also known as 4‑Hydroxy‑DiPT or 4‑HO‑DiPT) | | (19) | 4‑Hydroxy‑N,N‑dimethyltryptamine (also known as Psilocin) | | (20) | 4‑Hydroxy‑N‑methyl‑N‑ethyltryptamine (also known as 4‑Hydroxy‑MET or 4‑HO‑MET) | | (21) | 4‑Hydroxy‑N‑methyl‑N‑isopropyltryptamine (also known as 4‑Hydroxy‑MiPT or 4‑HO‑MiPT) | | (22) | 4‑Hydroxy‑α‑methyltryptamine (also known as 4‑Hydroxy‑AMT or 4‑HO‑AMT) | | (23) | 5‑Hydroxy‑N‑methyltryptamine (also known as 5‑Hydroxy‑NMT or 5‑HO‑NMT) | | (24) | 5‑Hydroxy‑N,N‑dimethyltryptamine (also known as Bufotenine) | | (25) | 5‑Methoxy‑N,N‑diallyltryptamine (also known as 5‑Methoxy‑DALT or 5‑MeO‑DALT) | | (26) | 5‑Methoxy‑N,N‑diethyltryptamine (also known as 5‑Methoxy‑DET or 5‑MeO‑DET) | | (27) | 5‑Methoxy‑N,N‑diisopropyltryptamine (also known as 5‑Methoxy‑DiPT or 5‑MeO‑DiPT) | | (28) | 5‑Methoxy‑N,N‑dimethyltryptamine (also known as 5‑Methoxy‑DMT or 5‑MeO‑DMT) | | (29) | 5‑Methoxy‑N,N‑dipropyltryptamine (also known as 5‑Methoxy‑DPT or 5‑MeO‑DPT) | | (30) | 5‑Methoxy‑N‑ethyl‑N‑isopropyltryptamine (also known as 5‑Methoxy‑EiPT or 5‑MeO‑EiPT) | | (31) | 5‑Methoxy‑N‑ethyl‑N‑propyltryptamine (also known as 5‑Methoxy‑EPT or 5‑MeO‑EPT) | | (32) | 5‑Methoxy‑α‑ethyltryptamine (also known as 5‑Methoxy‑AET or 5‑MeO‑AET) | | (33) | 5‑Methoxy‑N‑methyl‑N‑isopropyltryptamine (also known as 5‑Methoxy‑MiPT or 5‑MeO‑MiPT) | | (34) | 5‑Methoxy‑α‑methyltryptamine (also known as 5‑Methoxy‑AMT or 5‑MeO‑AMT) | | (35) | 5‑Methoxy‑N‑methyltryptamine (also known as 5‑Methoxy‑NMT or 5‑MeO‑NMT) | | (36) | 4‑Methyl‑α‑ethyltryptamine (also known as 4‑Methyl‑AET) | | (37) | 5‑Methyltryptamine | | (38) | α‑Methyltryptamine | | (39) | N‑Methyltryptamine”. |
|
|
|
|
